<DOC>
	<DOC>NCT00549614</DOC>
	<brief_summary>The primary objective of this study is to evaluate whether metabolic modulation improves left ventricular function, work capacity, insulin sensitivity and modifies substrate metabolism in chronic heart failure</brief_summary>
	<brief_title>Effect of 4 Weeks Treatment With Acipimox in Patients With Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Acipimox</mesh_term>
	<criteria>EF&lt;40 % IHD NYHAclass IIIII. pregnancy severe renal failure new brady or tachyArrhythmia Severe stenotic valvular disease myocardial infarction within last 6 weeks insulin treated diabetes mellitus peptic ulcer pregnancy or lactating women allergy towards tested medicine</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>heart failure</keyword>
</DOC>